Facial subcutaneous dermatofibrosarcoma protuberans treated with imatinib and monitored with magnetic resonance: A therapeutic alternative for unresectable cases.
Dermatol Ther
; 35(6): e15446, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-35293090
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Dermatofibrosarcoma
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Dermatol Ther
Journal subject:
DERMATOLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Chile